Double-blind placebo-controlled trial buflomedil treatment Raynaud phenomenon six-month follow-up efficacy buflomedil mean daily frequency severity winter ischemic attacks randomized double-blind placebo-controlled trial patients buflomedil group placebo group idiopathic Raynaud phenomenon months efficacy nail fold capillaroscopy significant alleviation hemodymanic disturbances background pallor comparison placebo Results terms clinical laboratory safety parameters six-month period satisfactory possibility long-term treatment 